ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999

Funding Opportunities.

May 3, 2002

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977